Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
15.25 SEK | -0.65% | -5.86% | +103.33% |
05-27 | Sweden’s IRLAB Therapeutics Names New CEO | MT |
05-27 | IRLAB Therapeutics AB Announces CEO Changes, Effective from August 1, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+103.33% | 76.43M | |
+42.60% | 748B | |
+34.05% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+17.23% | 245B | |
+9.45% | 211B | |
-3.84% | 209B | |
+1.81% | 166B |
- Stock Market
- Equities
- IRLAB A Stock
- News IRLAB Therapeutics AB
- Transcript : IRLAB Therapeutics AB, Q1 2024 Earnings Call, May 08, 2024